Monthly Archives: October 2022

Lecanemab in Alzheimer’s Disease

      Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #22.13     Lecanemab shows positive outcomes in Alzheimer’s disease     On September 28, Eisai and Biogen issued a press release where they announced that lecanemab, an investigational anti-amyloid beta protofibril monoclonal antibody, discovered by Bioartic Neuroscience in […]

read more

        Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #22.12     La Chine en 2022     Depuis l’invasion de l’Ukraine par la Russie de Vladimir Poutine un nombre croissant d’analogies avec les tensions géopolitiques entre la République Populaire de Chine (RPC) et Taiwan ont été mises […]

read more